Caricamento azienda
Just reported
Q3 FY2027 results
From Usana Health Sciences's results release of 3 novembre 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Revenue
Actual
205,9M USD
-3,6% y/y
-7,8% q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Usana Health Sciences is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Packaged Foods
Graded A or B and worth $2B or more: A first, then the largest.
SJMJ M Smucker Co14,2B USDA
MKCMccormick & Company, Incorporated12,7B USDA+
FRPTFreshpet, Inc.3,3B USDA
DARDarling Ingredients Inc.8,7B USDB+
POSTPost Holdings, Inc.3,6B USDB
Grade rose recently in Consumer Staples
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
BUDAnheuser-Busch InBev SA30 lug 2026BAGraded B, now A
MDLZMondelez International, Inc.29 ott 2026CAGraded C, now A
HSYHershey Co.29 ott 2026BAGraded B, now A
SYYSysco Corporation4 nov 2026BAGraded B, now A
ELFe.l.f. Beauty, Inc.4 nov 2026BAGraded B, now A
Costruito dai documenti depositati da Usana Health Sciences, Inc. presso la Securities and Exchange Commission (SEC), l’autorità di vigilanza statunitense. Le cifre sono quelle dichiarate, con lo storico per azione ricalcolato sulla base azionaria di oggi. Questo descrive un’azienda: non è consulenza finanziaria né una raccomandazione di acquisto o vendita.
